Expanded CD4+, DN and CD8α+ iNKT cells kill CD1d+ target cell lines and primary CD1d+ leukemia cells, with CD8α+ iNKT cells displaying the most potent cytotoxic activity. This evidence concerns the gene CD1D and leukemia.